DARA
BioSciences. DARA announced today it
has a completed a series of agreements with a number of specialty
pharmacy providers, leading group purchasing organizations (GPOs),
retail partners, reimbursement experts, and an industry-leading
third-party logistics provider. DARA believes these agreements provide
the company comprehensive commercial coverage across the national
oncology market.
As part of an integrated national network with annual sales of over $1
billion in cancer therapeutics, DARA has significantly enhanced its
commercial scale and capabilities. Its distribution network now consists
of more than 45,000 retail pharmacies, mail order pharmacies, and
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in